RNA Targeted Therapeutics Market SIZE AND SHARE ANALYSIS - GROWTH TRENDS AND FORECASTS (2024 - 2031)
RNA Targeted Therapeutics Market is Segmented By Type of Target Molecule (Cap Binding Complex, CDKL5, Dystrophin Protein, Erα, G542X, MNK1 / MNK2, PAX6 gene, SMN2), By Type of Approach (Indirect RNA Targeting: Epitranscriptomics, mRNA Translation Modulation, RNA Splicing Modification), By Geography (North America, Latin America, Asia Pacific, Europe, Middle East, and Africa). The report offers the value (in USD billion) for the above-mentioned segments.
Competitive overview of RNA Targeted Therapeutics Market
The major players operating in the RNA targeted therapeutics market include Abivax, AC Immune, Arrakis Therapeutics, eFFECTOR Therapeutics, Eloxx Pharmaceuticals, H3 Biomedicine, PTC Therapeutics, Ribometrix, Skyhawk Therapeutics and STORM Therapeutics.
RNA Targeted Therapeutics Market Leaders
- Abivax
- AC Immune
- Arrakis Therapeutics
- eFFECTOR Therapeutics
- Eloxx Pharmaceuticals
*Disclaimer: Major players are listed in no particular order.
RNA Targeted Therapeutics Market - Competitive Rivalry, 2023
RNA Targeted Therapeutics Market
Market Consolidated
(Dominated by major players)
(Dominated by major players)
Market Fragmented
(Highly competitive with lots of players.)
(Highly competitive with lots of players.)
*Source: Coherent Market Insights